Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Leiomyoma 5Breast Neoplasms 4Prostatic Neoplasms 3Pituitary Diseases 3Pituitary ACTH Hypersecretion 3Cushing Syndrome 3ACTH Syndrome, Ectopic 3Ovarian Neoplasms 2Hirsutism 2Fallopian Tube Neoplasms 2Choristoma 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms, Male 2Adrenal Cortex Neoplasms 2Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 1Uterine Hemorrhage 1Sarcoma 1Meningioma 1Endometrial Stromal Tumors 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

asoprisnil 6ulipristal acetate 2Mifepristone 1High-Energy Shock Waves 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Hemorrhage × Mifepristone × Clear all
NCT00881140 2012-12-19

Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

BioPro Medical Ltd

Phase 2 Completed
30 enrolled
Gynecologic

Leiomyoma, Uterine Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡